Sentences with phrase «potential than the developed markets»

«We'll be happy with the 1 % to 2 % growth in the developed North American markets and maintain our presence there,» says Saputo, «but we're tapping into emerging markets that are showing more growth potential than the developed markets.»

Not exact matches

Now, that's more than $ 20 of sales given away - but the offer is opening up potential sales to all those latecomers, and building up a potentially priceless presence on Foursquare as the site's full marketing potential develops.

These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).

As part of a long - term strategy, EM equity funds offer investors the potential for greater returns than they might get if they invest exclusively in developed markets.

Despite the safeguards it affords, they say, mothers in developing countries - the most vulnerable of mothers anywhere, the ones least able to afford formula milk, the ones whose babies most need the breast milk they could and should be getting for free - were being, and continue to be, targeted by corporate giants bent on carving out their share of a valuable market (Save the Children, which today publishes a report on the baby - milk industry, reckons that the total value of baby - milk and baby - food imports is worth almost # 16m a year in Bangladesh alone - but the potential, if more mothers were bottlefeeding, is a lot higher than that).

Now researchers reporting in ACS Sensors say they have developed a fast gluten detector that has the potential to detect and quantify different sources of gluten than those on the market today.

Emerging markets are more volatile than developed markets and have a wider range of potential outcomes.

After abandoning these markets in the past few years global investors are slowly returning back to them in order to profit from higher growth potential than in developed markets.

Emerging economies might offer greater growth potential than advanced economies, but the stocks of companies located in emerging markets could be substantially more volatile, risky, and less liquid than the stocks of companies located in more developed foreign markets.

Climate science has unintentionally become one of the most significant fronts in the socioeconomic - political struggle to develop a sustainable better future for humanity, a struggle to correct incorrect developments that have developed powerful defences, particularly through regionally temporarily successful misleading marketing appeals to developed temptations for more potential personal benefit rather than desiring to be more helpful to others and the future of humanity.

These people are unlikely to stop unless it is clear to them that there is greater likelihood of a personal negative consequence that is more significant than the potential benefit they hope to personally obtain, a perception of potential benefit being sold through deceptive marketing promoted by the kingpins of the pyramid schemes of unsustainable and damaging activity developed and promoted and prolonged in the political - economic system.

In an effort to push forward, the Energy Commission developed a new study of market potential for combined heat and power facilities that includes facilities smaller than 20 megawatts in size that do not typically have excess power to export to the grid.

Accomplished product strategist and leader with over 11 years of experience conceptualizing, developing and launching more than half a dozen market - driven technology solutions for the financial services industry * Innovative technology leader currently overseeing the strategic framework and development for a new, integrated product line with potential future revenues of over $ 100MM targeting a previously untapped buy - side m...